2bey

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
A novel bifunctional bicyclic inhibitor has been created that combines, features both from the Bowman-Birk inhibitor (BBI) proteins, which have, two distinct inhibitory sites, and from sunflower trypsin inhibitor-1, (SFTI-1), which has a compact bicyclic structure. The inhibitor was, designed by fusing together a pair of reactive loops based on a sequence, derived from SFTI-1 to create a backbone-cyclized disulfide-bridged 16-mer, peptide. This peptide has two symmetrically spaced trypsin binding sites., Its synthesis and biological activity have been reported in a previous, communication [Jaulent and Leatherbarrow, 2004, PEDS 17, 681]. In the, present study we have examined the three-dimensional structure of the, molecule. We find that the new inhibitor, which has a symmetrical 8-mer, half-cystine CTKSIPP'I' motif repeated through a C2 symmetry axis also, shows a complete symmetry in its three-dimensional structure. Each of the, two loops adopts the expected canonical conformation common to all BBIs as, well as SFTI-1. We also find that the inhibitor displays a strong and, unique structural identity, with a notable lack of minor conformational, isomers that characterise most reactive site loop mimics examined to date, as well as SFTI-1. This suggests that the presence of the additional, cyclic loop acts to restrict conformational mobility and that the, deliberate introduction of cyclic symmetry may offer a general route to, locking the conformation of beta-hairpin structures.
+
A novel bifunctional bicyclic inhibitor has been created that combines features both from the Bowman-Birk inhibitor (BBI) proteins, which have two distinct inhibitory sites, and from sunflower trypsin inhibitor-1 (SFTI-1), which has a compact bicyclic structure. The inhibitor was designed by fusing together a pair of reactive loops based on a sequence derived from SFTI-1 to create a backbone-cyclized disulfide-bridged 16-mer peptide. This peptide has two symmetrically spaced trypsin binding sites. Its synthesis and biological activity have been reported in a previous communication [Jaulent and Leatherbarrow, 2004, PEDS 17, 681]. In the present study we have examined the three-dimensional structure of the molecule. We find that the new inhibitor, which has a symmetrical 8-mer half-cystine CTKSIPP'I' motif repeated through a C2 symmetry axis also shows a complete symmetry in its three-dimensional structure. Each of the two loops adopts the expected canonical conformation common to all BBIs as well as SFTI-1. We also find that the inhibitor displays a strong and unique structural identity, with a notable lack of minor conformational isomers that characterise most reactive site loop mimics examined to date as well as SFTI-1. This suggests that the presence of the additional cyclic loop acts to restrict conformational mobility and that the deliberate introduction of cyclic symmetry may offer a general route to locking the conformation of beta-hairpin structures.
==About this Structure==
==About this Structure==
Line 12: Line 12:
Solution structure of a novel C2-symmetrical bifunctional bicyclic inhibitor based on SFTI-1., Jaulent AM, Brauer AB, Matthews SJ, Leatherbarrow RJ, J Biomol NMR. 2005 Sep;33(1):57-62. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=16222558 16222558]
Solution structure of a novel C2-symmetrical bifunctional bicyclic inhibitor based on SFTI-1., Jaulent AM, Brauer AB, Matthews SJ, Leatherbarrow RJ, J Biomol NMR. 2005 Sep;33(1):57-62. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=16222558 16222558]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Brauer, A.B.E.]]
+
[[Category: Brauer, A B.E.]]
-
[[Category: Jaulent, A.M.]]
+
[[Category: Jaulent, A M.]]
-
[[Category: Leatherbarrow, R.J.]]
+
[[Category: Leatherbarrow, R J.]]
-
[[Category: Matthews, S.J.]]
+
[[Category: Matthews, S J.]]
[[Category: bikk]]
[[Category: bikk]]
[[Category: c2 symmetrical bifunctional bicyclic trypsin inhibitor]]
[[Category: c2 symmetrical bifunctional bicyclic trypsin inhibitor]]
Line 22: Line 22:
[[Category: symmetry]]
[[Category: symmetry]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Feb 3 10:23:16 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:37:14 2008''

Revision as of 14:37, 21 February 2008


2bey

Drag the structure with the mouse to rotate

SOLUTION STRUCTURE OF A NOVEL C2 SYMMETRICAL BIFUNCTIONAL BICYCLIC INHIBITOR BASED ON SFTI-1

Overview

A novel bifunctional bicyclic inhibitor has been created that combines features both from the Bowman-Birk inhibitor (BBI) proteins, which have two distinct inhibitory sites, and from sunflower trypsin inhibitor-1 (SFTI-1), which has a compact bicyclic structure. The inhibitor was designed by fusing together a pair of reactive loops based on a sequence derived from SFTI-1 to create a backbone-cyclized disulfide-bridged 16-mer peptide. This peptide has two symmetrically spaced trypsin binding sites. Its synthesis and biological activity have been reported in a previous communication [Jaulent and Leatherbarrow, 2004, PEDS 17, 681]. In the present study we have examined the three-dimensional structure of the molecule. We find that the new inhibitor, which has a symmetrical 8-mer half-cystine CTKSIPP'I' motif repeated through a C2 symmetry axis also shows a complete symmetry in its three-dimensional structure. Each of the two loops adopts the expected canonical conformation common to all BBIs as well as SFTI-1. We also find that the inhibitor displays a strong and unique structural identity, with a notable lack of minor conformational isomers that characterise most reactive site loop mimics examined to date as well as SFTI-1. This suggests that the presence of the additional cyclic loop acts to restrict conformational mobility and that the deliberate introduction of cyclic symmetry may offer a general route to locking the conformation of beta-hairpin structures.

About this Structure

2BEY is a Single protein structure of sequence from [1]. Known structural/functional Site: . Full crystallographic information is available from OCA.

Reference

Solution structure of a novel C2-symmetrical bifunctional bicyclic inhibitor based on SFTI-1., Jaulent AM, Brauer AB, Matthews SJ, Leatherbarrow RJ, J Biomol NMR. 2005 Sep;33(1):57-62. PMID:16222558

Page seeded by OCA on Thu Feb 21 16:37:14 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools